Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
EQRx, Inc. EQRXW
$0.15
+$0 (0.07%)
На 18:04, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
0.21
-
week52low
0.15
-
Revenue
0
-
P/E TTM
814
-
Beta
0.00000000
-
EPS
-7.65300000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 мая 2023 г. в 07:43
Описание компании
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EGFR-mutated non-small cell lung cancer (NSCLC); and Sugemalimab, an anti-programmed death-ligand 1 antibody for the treatment of Stage III and Stage IV NSCLC. Its other programs in pipeline include clinical and pre-clinical stage assets, which comprise Lerociclib, a small molecule cyclin-dependent kinase 4/6 inhibitor, which is in Phase I clinical trials in patients with metastatic breast cancer; EQ176, an anti-programmed death-1 antibody that is in Phase III trials for the treatment of patients with primary liver cancer; and EQ121, a selective janus kinase-1 inhibitor that is in various Phase I trials. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| AH Equity Partners LSV I, L.L.C. | A | 1574510 | 8246 | 01 янв 2023 г. |
| AH Equity Partners LSV I, L.L.C. | A | 2642897 | 13842 | 01 янв 2023 г. |
| AH Equity Partners LSV I, L.L.C. | A | 2401418 | 12577 | 01 янв 2023 г. |
| Nallicheri Melanie | A | 530335 | 2777 | 01 янв 2023 г. |
| Nallicheri Melanie | A | 1041108 | 5453 | 01 янв 2023 г. |
| AH Equity Partners Bio II, L.L.C. | A | 1574510 | 8246 | 01 янв 2023 г. |
| AH Equity Partners Bio II, L.L.C. | A | 2642897 | 13842 | 01 янв 2023 г. |
| AH Equity Partners Bio II, L.L.C. | A | 2401418 | 12577 | 01 янв 2023 г. |
| BERNS PAUL L | A | 86344 | 453 | 01 янв 2023 г. |
| MEANWELL CLIVE | A | 43172 | 226 | 01 янв 2023 г. |
Свежие комментарии
Свежие комментарии